Hemophagocytic Lymphohistiocytosis in Adults: Why It Gets Confused With Sepsis, Severe Infection, or Cytokine Storm

A very sick adult arrives with high fever, low blood pressure, worsening organ dysfunction, abnormal liver tests, falling blood counts, and a lab picture that suggests overwhelming inflammation. In many hospitals, the first working diagnosis in that situation is sepsis. That instinct is understandable, because sepsis is common, dangerous, and must be treated quickly. But sometimes the patient is not dealing with ordinary sepsis alone. Sometimes the immune system itself is in uncontrolled overdrive, creating a syndrome called Hemophagocytic lymphohistiocytosis.

Hemophagocytic lymphohistiocytosis in adults is a rare but life-threatening hyperinflammatory condition in which immune cells become excessively activated and begin driving widespread tissue damage, organ dysfunction, and a storm of inflammatory signaling. Adults usually develop it as a secondary condition, meaning it is triggered by something else such as infection, cancer, autoimmune disease, immune dysregulation, or certain therapies and transplants. The problem is that the early presentation can look almost identical to severe infection, septic shock, or the broader group of illnesses often described as cytokine storm syndromes. That is one reason diagnosis is frequently delayed.

That delay matters. Hemophagocytic lymphohistiocytosis is not just “bad inflammation.” It is a medical emergency with a high risk of multiorgan failure and death if it is not recognized and treated promptly. Unlike routine sepsis treatment, management often requires active suppression of the hyperinflammatory immune response while also identifying and treating the underlying trigger. In other words, the condition may begin by looking like infection, but it often needs a very different diagnostic mindset and a different treatment strategy.

Hemophagocytic lymphohistiocytosis is a syndrome of uncontrolled immune activation. The normal checks and balances that help the body clear infected or abnormal cells without excessive collateral damage stop working effectively. Activated immune cells and macrophages continue releasing inflammatory signals, which leads to tissue injury, cytopenias, liver dysfunction, clotting abnormalities, and failure of multiple organs. In children, inherited forms are more prominent. In adults, however, secondary or acquired disease is much more common.

Adult cases are often linked to major triggers. Common categories include viral and other infections, blood cancers such as lymphoma or leukemia, autoimmune or rheumatologic disease, and immune disturbances after transplantation or certain immune therapies. Among adults, malignancy is a particularly important trigger category, and clinicians are often warned that if no obvious cause is found in a very sick adult with suspected Hemophagocytic lymphohistiocytosis, an underlying cancer must be considered carefully.

The simplest reason is that the overlap is real. Adults with Hemophagocytic lymphohistiocytosis commonly present with fever, profound systemic inflammation, low blood counts, liver injury, respiratory distress, altered mental status, kidney dysfunction, and shock. Those features are not unique. They are also seen in severe infection and septic shock. On top of that, infection is often the trigger for Hemophagocytic lymphohistiocytosis in the first place, which means the two conditions can coexist rather than cleanly substitute for one another.

Another reason for confusion is that adult diagnostic criteria were not originally built around the typical intensive care unit presentation. Many hospitals are quicker to work up sepsis than to order the specialized tests used in Hemophagocytic lymphohistiocytosis evaluation. Soluble interleukin-2 receptor testing and natural killer cell activity testing, for example, may not be readily available everywhere. That practical limitation can delay recognition, especially when the patient already has a plausible infectious explanation for their condition.

There is also a psychological issue in real-world practice: sepsis is common, Hemophagocytic lymphohistiocytosis is uncommon, and rare diagnoses are easy to miss when a common one seems to fit the case. As a result, adults with presumed sepsis who do not improve as expected, who have striking ferritin elevation, or who develop unexplained cytopenias and organ failure may actually have an unrecognized hyperinflammatory syndrome underneath the initial diagnosis.

The term cytokine storm is often used broadly to describe dangerous immune overactivation. Hemophagocytic lymphohistiocytosis belongs within that broader hyperinflammatory landscape, but it is not interchangeable with every other cytokine storm syndrome. The problem is that the same words are often used loosely in hospitals, journal articles, and media discussions, especially after the coronavirus era increased public awareness of immune overreaction. This broad usage can blur distinctions between Hemophagocytic lymphohistiocytosis, macrophage activation syndrome, severe viral hyperinflammation, and infection-related inflammatory collapse.

In practical terms, many patients with Hemophagocytic lymphohistiocytosis look like they have “cytokine storm,” but not every patient with cytokine storm has Hemophagocytic lymphohistiocytosis. That is why a structured diagnostic approach matters. The overlap is real, but the labels are not interchangeable, and treatment decisions can change depending on which syndrome is actually present.

Early symptoms in adults are often nonspecific. Fever is extremely common. Many patients have profound fatigue, malaise, weight loss, confusion, or rapidly worsening illness without one single symptom pointing clearly to the diagnosis. Enlarged liver or spleen may be present, but not always obvious on first evaluation. Respiratory failure, hepatitis, coagulopathy, encephalopathy, and kidney injury can all develop, especially in critically ill patients.

This is part of the trap. A patient with fever, liver dysfunction, low blood pressure, and respiratory failure can very reasonably be labeled as severe infection on day one. If broad-spectrum antimicrobials are started, cultures are sent, and the case is treated as septic shock, that is often appropriate initially. The mistake is not starting sepsis treatment. The mistake is failing to revisit the diagnosis when the pattern becomes unusual or the patient worsens despite appropriate therapy.

Several lab abnormalities show up repeatedly in adult Hemophagocytic lymphohistiocytosis. The most important ones include:

• Very high ferritin
• Cytopenias affecting two or more blood cell lines
• High triglycerides
• Low fibrinogen
• Liver enzyme elevation
• Evidence of coagulopathy or disseminated inflammation
• Elevated soluble interleukin-2 receptor when available

Fever, splenomegaly, hemophagocytosis on tissue sampling, low or absent natural killer cell activity, and ferritin above the threshold used in the classic criteria are all part of the traditional diagnostic framework. In practice, however, clinicians know that adult disease often declares itself through the overall pattern rather than one lab number alone.

Among these tests, ferritin has become one of the most talked-about markers. Extremely high ferritin is not specific to Hemophagocytic lymphohistiocytosis, but it is one of the strongest clues that routine sepsis may not be the whole story. The classic threshold in the Hemophagocytic lymphohistiocytosis criteria is ferritin above 500 nanograms per milliliter, but adult reviews emphasize that clinically significant adult cases often have much higher levels, often in the thousands and sometimes far above 10,000. Consensus guidance has noted that ferritin values characteristic of adult Hemophagocytic lymphohistiocytosis are often above 7,000 to 10,000 micrograms per liter, although other conditions can also cause severe hyperferritinemia.

One classic study found that ferritin above 10,000 micrograms per liter was highly sensitive and specific for Hemophagocytic lymphohistiocytosis in the studied population, but that finding came from a mixed and largely pediatric context and should not be treated as a stand-alone adult rule. In adults, ferritin helps raise suspicion, but it does not confirm the diagnosis by itself.

Ferritin is powerful, but it is not magic. Severe infection, liver failure, autoimmune disease, malignancy, and other inflammatory states can also push ferritin very high. That is why a patient with high ferritin and shock is not automatically diagnosed with Hemophagocytic lymphohistiocytosis. The right question is not “Is ferritin elevated?” but “Does the patient have the pattern of extreme inflammation, falling blood counts, coagulopathy, organ dysfunction, and a trigger profile consistent with Hemophagocytic lymphohistiocytosis?”

Recent work comparing Hemophagocytic lymphohistiocytosis with other inflammatory syndromes has reinforced that ferritin tends to be markedly higher in Hemophagocytic lymphohistiocytosis than in some other cytokine storm conditions, but overlap still exists. That is why ferritin is best understood as a major clue rather than a final answer.

In adult critical care discussions, one practical message keeps appearing: think harder about Hemophagocytic lymphohistiocytosis when there is persistent fever, falling blood counts, and very high ferritin, especially if the patient is not improving with standard infection treatment or there is no clear infectious source. This combination is especially concerning when accompanied by worsening liver tests, hypofibrinogenemia, or splenomegaly.

This matters because sepsis alone often produces inflammation and organ injury, but the specific combination of persistent high fever, progressive cytopenias, marked hyperferritinemia, and coagulation abnormalities should push clinicians to consider whether a hyperinflammatory syndrome is driving the collapse.

The traditional Hemophagocytic lymphohistiocytosis 2004 criteria remain widely used. These criteria allow diagnosis when a known disease-associated mutation is found or when at least five of eight clinical and laboratory criteria are met. Those eight include fever, splenomegaly, cytopenias, hypertriglyceridemia or hypofibrinogenemia, hemophagocytosis on biopsy, low or absent natural killer cell activity, elevated ferritin, and high soluble interleukin-2 receptor levels.

The limitation is that these criteria were developed in pediatric settings and do not perfectly fit adult hospital practice. Adults may present before all criteria are fulfilled, and some required tests are not immediately available. Waiting passively for full criteria fulfillment can be dangerous if the patient is deteriorating quickly. That is why experienced adult clinicians often combine the formal criteria with overall pattern recognition and serial reassessment.

Because adult Hemophagocytic lymphohistiocytosis often sits in a gray zone between obvious sepsis and obvious immune dysregulation, the HScore was developed as a probability-based tool for reactive Hemophagocytic lymphohistiocytosis. It uses nine variables, including underlying immunosuppression, temperature, organ enlargement, triglycerides, ferritin, liver enzymes, fibrinogen, cytopenias, and hemophagocytosis on bone marrow aspirate. The original validation study concluded that the HScore could estimate an individual’s probability of reactive hemophagocytic syndrome, and later work has supported its usefulness in adult evaluation. A score of 169 or more is often cited as an important diagnostic threshold in practice, though it should still be interpreted in clinical context.

The value of the HScore is not that it replaces clinical judgment. Its value is that it gives clinicians a structured way to quantify concern in adults whose illness may otherwise be dismissed as “just severe infection.”

Many people assume the diagnosis requires hemophagocytosis on bone marrow examination. In reality, that is a common misunderstanding. Hemophagocytosis can support the diagnosis, but it is not mandatory, and it may be absent early in the disease. Conversely, hemophagocytosis is not unique to Hemophagocytic lymphohistiocytosis and can occur in other severe inflammatory states. So a negative marrow sample does not rule out the syndrome, and a positive sample does not prove it by itself.

This is another reason adult cases are missed. If clinicians wait for perfect biopsy confirmation before acting, valuable time may be lost.

Some adult scenarios should trigger a much lower threshold for considering Hemophagocytic lymphohistiocytosis:

Epstein-Barr virus, cytomegalovirus, tuberculosis, fungal infections, and other severe infections can trigger the syndrome. In these cases, clinicians may initially believe the infection alone explains everything, when in fact the infection has triggered runaway immune activation that now requires more than antimicrobials.

Blood cancers, especially lymphomas, are major adult triggers. Adult reviews emphasize that malignancy-associated Hemophagocytic lymphohistiocytosis often carries particularly poor outcomes and needs urgent recognition.

In some patients, the syndrome emerges alongside autoimmune disease or macrophage activation syndrome. These patients may initially be thought to have infection, autoimmune flare, or drug reaction rather than Hemophagocytic lymphohistiocytosis.

The distinction is not always neat, but several features should push the differential diagnosis away from uncomplicated sepsis:

• the patient is worsening despite appropriate infection treatment
• no convincing infectious source is found
• ferritin is dramatically elevated
• blood counts keep falling across more than one cell line
• fibrinogen drops while triglycerides rise
• splenomegaly or hepatosplenomegaly is present
• liver injury is disproportionate
• there is an underlying trigger such as lymphoma, Epstein-Barr virus, autoimmune disease, or transplant-related immune dysregulation

None of these findings alone proves Hemophagocytic lymphohistiocytosis. Together, however, they form the pattern that clinicians are warned not to ignore.

This is where the distinction becomes lifesaving. Sepsis treatment focuses on source control, antimicrobials, hemodynamic support, and organ support. Hemophagocytic lymphohistiocytosis treatment still requires identifying and treating triggers, but it often also requires immunosuppression or targeted anti-inflammatory therapy, such as dexamethasone, etoposide-based treatment in many settings, and in some cases cytokine inhibitors or other newer therapies. Expert references emphasize that treatment may need to begin when the disorder is strongly suspected rather than waiting for every criterion to be formally met.

That creates one of the hardest clinical balancing acts in adult medicine: treating a possible infection aggressively while also deciding whether the inflammatory response has become dangerous enough to warrant directed Hemophagocytic lymphohistiocytosis therapy.

A useful way to think about adult Hemophagocytic lymphohistiocytosis is this: it should move up the differential when a patient with presumed sepsis looks too inflamed, too cytopenic, too ferritin-high, or too refractory to treatment for ordinary infection alone. This is especially true if there is a compatible trigger such as lymphoma, Epstein-Barr virus, autoimmune disease, or unexplained hepatosplenomegaly.

For non-specialists reading their own lab reports or hospital notes, the main takeaway is not to self-diagnose. It is to understand why doctors become concerned when fever, very high ferritin, falling blood counts, liver injury, and severe systemic illness cluster together. Hemophagocytic lymphohistiocytosis is rare, but it is exactly the kind of rare diagnosis that becomes dangerous when nobody thinks to look for it.

Hemophagocytic lymphohistiocytosis in adults is often mistaken for sepsis, severe infection, or cytokine storm because the early illness can look almost identical: fever, shock, organ dysfunction, abnormal inflammatory markers, and rapid clinical deterioration. The overlap is real, and infection may even be the trigger. But what separates Hemophagocytic lymphohistiocytosis is the pattern of uncontrolled immune activation, often signaled by very high ferritin, cytopenias, hypofibrinogenemia, hypertriglyceridemia, organ enlargement, and failure to improve as expected with standard infection treatment.

The earlier that pattern is recognized, the better the chance of timely evaluation and appropriate therapy. In adults, the diagnostic challenge is not that Hemophagocytic lymphohistiocytosis hides completely. It is that it often hides inside a far more familiar picture.

References: